Bridge7 selected for Canada's Google for Startups Accelerator

bridge7_Oncology.png

Bridge7 was announced as one of nine startups selected for the inaugural cohort of Canada’s Google for Startups Accelerator. Launched via the U of T Early-Stage Technology program (UTEST), Bridge7 uses AI to accelerate the triaging and treatment of cancer patients.

Previous
Previous

2020 Texas Life Science Forum: Call for Presenters

Next
Next

Health Canada approves rapid COVID testing device